Specialty Pharmacy

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct but have not spread to other tissues in the breast.

For specialty pharmacies, contingency plans for COVID-19 are not as simple as moving a workforce to their remote access solutions.

Ozanimod demonstrated acceptable safety and tolerability in the phase 3 SUNBEAM and RADIANCE part B trials.

New research has examined the details surrounding the signaling molecule interleukin-2, which could lead to more targeted therapies for diseases such as cancer.

Guidelines recommend that Ashkenazi Jewish women discuss genetic testing with physicians, but other women with breast cancer are less likely to receive a recommendation of testing.

A study published in Clinical Cancer Research has shown that using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC) can predict tumor sensitivity to 3 systematic cancer therapies by using artificial intelligence (AI).

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Research may lead to the development of new types of binding proteins for biological sugar structures, which play a significant role in cancer and infectious diseases.

Patients with a history of cancer have a greater likelihood of developing atrial fibrillation, the most common heart rhythm disorder, compared with the general population.

Trastuzumab-dttb was first approved in January 2019 across all eligible indications, mainly adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer.

The FDA has issued a new guidance to sponsors and health care providers regarding certain Risk Evaluation and Mitigation Strategy-required testing during the coronavirus disease 2019 pandemic.

The phase 3 trial showed a statistically significant improvement in overall survival (OS) and composite complete remission rate.

The growth of the pipeline has led to increases in insurance carriers’ specialty plan spend.

Pharmacy Moms Group special task force develops guidelines as precautions are implemented amid the COVID-19 pandemic.

Only 15% of those at risk are currently using PrEP.

Statins, widely used to lower cholesterol and prevent heart disease, may guard against heart damage caused by certain breast cancer therapies.

The 12 groups represent practice settings of nearly all pharmacists in the United States.

“We’re pretty devastated,” said Jessica Harris, a friend of Rutter, in an interview with WFSB. “She beat cancer and lost the battle to coronavirus—it’s just crazy.”

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

The drug was previously approved to treat HCV in adults

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

Now is the time for pharmacists to stand even taller and provide more help to their communities.

A new study shows that the advantages of digital breast tomosynthesis are maintained over multiple years and rounds of screening compared with digital mammography.

A clinical program evaluating sarilumab (Kevzara, Sanofi and Regeneron) has started in patients hospitalized with a severe form of the novel coronavirus (COVID-19), according to the company.

A growth hormone known as insulin-like growth factor-1 has been found to play a role in the development of breast cancer.

Top news from across the health care landscape.

Top news from across the health care landscape.

Top news of the week from Directions in Specialty PharmacyTM.